Active Ingredient: RANOLAZINE
Proprietary Name: ASPRUZYO SPRINKLE
Dosage Form; Route of Administration: GRANULES, EXTENDED RELEASE; ORAL
Strength: 500MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N216018
Product Number: 001
Approval Date: Feb 28, 2022
Applicant Holder Full Name: SUN PHARMA INDUSTRIES LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information
